Why Teva Pharmaceutical Is Soaring 13.5% Today
After providing investors with the details of its latest cost-savings plan, including a massive workforce reduction, Teva Pharmaceutical (NYSE: TEVA) shares are rallying 13.5% as of 1 p.m. EST Thursday.
It's been a brutal year for the world's biggest generic drugmaker. Shares have suffered significantly due to declining sales and profit due to lower generic drug prices, new competition for its best-selling drug, Copaxone, and higher interest expenses associated with its $40 billion acquisition of Allergan's (NYSE: AGN) generic drug business.
Image source: Getty Images.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Aktie
31,70 €
0,96 %
Klare Kaufempfehlung: Teva Pharmaceutical Industries Ltd ADR erhält nur Buy-Einschätzungen.
Die Community prognostiziert für Teva Pharmaceutical Industries Ltd ADR ein Kursziel von 34 €, was einen leichten Anstieg gegenüber 31.7 € darstellt.
